Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 381 posts found.

novo

Drug industry suing to overturn Minnesota insulin affordability law

July 2, 2020
Business Services diabetes, insulin, type 1, type 2

The drug industry is suing to overturn a Minnesota law that requires companies to provide emergency insulin to diabetics who …

News
type_2

New data from diabetes prevention programme shows a reduction of type 2 diabetes

June 17, 2020
Research and Development diabetes, type 2 diabetes

The Diabetes Prevention Program Outcomes Study (DPPOS) of 2,000 people showed a significant reduction in the participants’ risk of developing …

News
fda2outsideweb

Mylan and Biocon’s Semglee, biosimilar to Sanofi’s Lantus, approved by FDA for type 1 and 2 diabetes

June 12, 2020
Medical Communications, Sales and Marketing FDA, Lantus, Mylan Biocon, Sanofi, Semglee, diabetes

Mylan and Biocon have scored FDA approval with their insulin glargine injection Semglee, a biosimilar to Sanofi’s Lantus, in both …

News
diabetes_3

Type 1 diabetics more likely to die from COVID-19 than type 2, according to the NHS

May 20, 2020
Research and Development COVID-19, Diabetics, coronavirus, diabetes

People suffering type 1 diabetes are far more likely to die of coronavirus than those with type 2, according to …

News
diabetes

A quarter of English COVID-19 deaths in hospitals were diabetics

May 15, 2020
Medical Communications COVID-19, coronavirus, diabetes

The NHS’s first data breakdown of underlying health conditions in COVID-19 fatalities has shown that 1 in 4 deaths in …

News
inzulin

Governor of Minnesota signs emergency bill for insulin access

April 17, 2020
Medical Communications diabetes, insulin, insulin copays, medical insurance

Minnesota Governor Tim Walz has signed legislation to provide a one-time, 30-day supply of insulin for eligible residents in urgent …

News

Patient Experience: Living with type 1 diabetes

April 14, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, diabetes, feature, patient experience

23-year-old US student Madelyn Lazra recently graduated with a BA in Business Law and certification in International Business, and is …

Feature
insulin

Eli Lilly will limit insulin costs to $35 per month for patients in the US due to COVID-19

April 8, 2020
Research and Development Eli Lilly, diabetes, insulin

Eli Lilly announced that it will limit out of pocket costs for insulin to $35 per month to offset the …

News
novo_nordisk_flag

European approval for Novo’s Rybelsus to control blood sugar in type 2 diabetes

April 6, 2020
Sales and Marketing Novo Nordisk, Rybelsus, diabetes, pharma

The European Commission has greenlighted Novo Nordisk’s Rybelsus (oral semaglutide) as an adjunct to diet and exercise to improve glycaemic …

News
fda2outsideweb

FDA turns down label expansion for Jardiance as an adjunct to insulin in type 1 diabetes

March 23, 2020
Sales and Marketing FDA, diabetes, jardiance, pharma

The FDA has chosen not to approve an expanded indication of 2.5mg Jardiance (empaglifozin) as an adjunct to insulin in …

News
4773288007_96679a394b_b

Fast-acting mealtime insulin approved for children with diabetes in Canada

March 10, 2020
Manufacturing and Production Type 1 diabetes, diabetes, insulin, insulin pump, type 2 diabetes

Health Canada has approved Novo Nordik’s Fiasp, a faster acting mealtime insulin, for children aged 2 and above with type …

News

Insulin pumps tied to over 2,000 injuries recalled

February 14, 2020
Medical Communications Type 1 diabetes, diabetes, insulin, type 1, type 2, type 2 diabetes

Over 300,000 insulin pumps have been recalled by Medtronic after injuries and one death were reported due to devices malfunctioning. …

News
mjg5mzc4oa

Type 2 diabetes drug Rosiglitazone increases risk of heart problems

February 12, 2020
Research and Development British Medical Journal, diabetes, heart failure, insulin, type 2, type 2 diabetes

A new study has given further evidence that rosiglitazone can contribute to risk of heart problems and heart failure. The …

News
type_2_diabetes_28081593711

Type 2 diabetes cases up 40% in Scotland

February 11, 2020
Manufacturing and Production Type 1 diabetes, diabetes, diabetes obesity, obesity, type 2 diabetes

According to a new study, Scotland’s cases of type 2 diabetes has increased by 40% over the last 10 years. …

News
novo_nordisk_flag

Novo’s semaglutide injection and tablets get expanded FDA approval for type 2 diabetes with established CVD

January 17, 2020
Medical Communications, Sales and Marketing FDA, Novo Nordisk, Ozempic, cardiovascular disease, diabetes, pharma

Novo Nordisk has seen label expansions approved from the FDA for both its glucagon-like peptide-1 (GLP-1) analogue injection Ozempic (once-weekly …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023